Christopher J. Senner - May 24, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Christopher J. Senner
Stock symbol
QNCX
Transactions as of
May 24, 2023
Transactions value $
$0
Form type
4
Date filed
5/26/2023, 05:53 PM
Previous filing
May 17, 2023
Next filing
Aug 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Award $0 +27K $0.00 27K May 24, 2023 Common Stock 27K $1.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of May 24, 2023.